Bioxytran (BIXT) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free BIXT Stock Alerts $0.13 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Bioxytran Short Interest DataCurrent Short Volume23,100 sharesPrevious Short Volume7,900 sharesChange Vs. Previous Month+192.41%Dollar Volume Sold Short$2,566.41Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares175,410,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume8,454 sharesAverage Trading Volume119,153 sharesToday's Volume Vs. Average7% Short Selling Bioxytran ? Sign up to receive the latest short interest report for Bioxytran and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIXT Short Interest Over TimeBIXT Days to Cover Over TimeBIXT Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Bioxytran Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202423,100 shares $2,566.41 +192.4%N/A0.1 $0.11 4/15/20247,900 shares $1,151.98 -86.0%N/A0 $0.15 3/31/202456,600 shares $5,988.28 +4.0%N/A0.5 $0.11 3/15/202454,400 shares $6,049.28 +92.9%N/A0.3 $0.11 2/29/202428,200 shares $3,102.00 No ChangeN/A0.2 $0.11 1/15/20241,700 shares $244.12 -89.5%N/A0 $0.14 Get the Latest News and Ratings for BIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. 12/31/202316,200 shares $2,430.00 -46.9%N/A0 $0.15 12/15/202330,500 shares $4,479.84 No ChangeN/A0.1 $0.15 11/15/202347,500 shares $7,120.25 +268.2%N/A0.4 $0.15 10/31/202312,900 shares $1,999.50 -77.0%N/A0.1 $0.16 10/15/202356,100 shares $9,537.00 +2.2%N/A0.5 $0.17 9/30/202354,900 shares $9,333.00 +173.1%N/A0.2 $0.17 9/15/202320,100 shares $3,015.00 -71.6%N/A0 $0.15 8/31/202370,700 shares $21,917.00 +644.2%N/A0.3 $0.31 8/15/20239,500 shares $1,368.00 +106.5%N/A0.2 $0.14 7/31/20234,600 shares $687.70 -87.9%N/A0 $0.15 7/15/202338,100 shares $5,715.00 -25.3%N/A0.4 $0.15 6/30/202351,000 shares $9,690.00 +4,150.0%N/A0.2 $0.19 6/15/20231,200 shares $276.00 -62.5%N/A0 $0.23 5/31/20233,200 shares $1,025.60 +88.2%N/A0.1 $0.32 5/15/20231,700 shares $680.00 -96.0%N/A0 $0.40 4/30/202342,900 shares $21,771.75 +263.6%N/A0.7 $0.51 4/15/202311,800 shares $5,742.77 -9.2%N/A0.1 $0.49 3/31/202313,000 shares $5,785.00 +14.0%N/A0.1 $0.45 3/15/202311,400 shares $5,141.40 No ChangeN/A0 $0.45 2/15/2023700 shares $292.25 No ChangeN/A0 $0.42 1/15/202317,400 shares $7,830.00 -17.1%N/A0.3 $0.45 12/30/202221,000 shares $10,080.00 +577.4%N/A0.2 $0.48 12/15/20223,100 shares $1,289.60 +121.4%N/A0 $0.42 11/30/20221,400 shares $588.14 -90.1%N/A0 $0.42 11/15/202214,200 shares $7,100.00 +136.7%N/A0.1 $0.50 10/31/20226,000 shares $2,400.00 +185.7%N/A0.1 $0.40 10/15/20222,100 shares $1,071.00 No ChangeN/A0 $0.51 9/15/20227,400 shares $6,956.00 -54.6%N/A0 $0.94 8/31/202216,300 shares $16,952.00 +3,160.0%N/A0.1 $1.04 8/15/2022500 shares $255.00 -73.7%N/A0 $0.51 7/31/20221,900 shares $798.00 -88.3%N/A0 $0.42 7/15/202216,200 shares $8,908.38 No ChangeN/A0.1 $0.55 12/31/2021300 shares $120.00 No ChangeN/A0 $0.40 12/15/2021300 shares $0.75 -25.0%N/A0.1 $0.00CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. BIXT Short Interest - Frequently Asked Questions What is Bioxytran's current short interest? Short interest is the volume of Bioxytran shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 23,100 shares of BIXT short. Learn More on Bioxytran's current short interest. Is Bioxytran's short interest increasing or decreasing? Bioxytran saw a increase in short interest in April. As of April 30th, there was short interest totaling 23,100 shares, an increase of 192.4% from the previous total of 7,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bioxytran's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bioxytran: Benitec Biopharma Inc. (6.27%), Cumberland Pharmaceuticals Inc. (0.23%), CytoMed Therapeutics Limited (1.08%), MEI Pharma, Inc. (0.37%), Bullfrog AI Holdings, Inc. (3.62%), Orgenesis Inc. (0.84%), Lumos Pharma, Inc. (6.09%), Alaunos Therapeutics, Inc. (9.57%), TherapeuticsMD, Inc. (0.46%), Synlogic, Inc. (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bioxytran stock? Short selling BIXT is an investing strategy that aims to generate trading profit from Bioxytran as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bioxytran? A short squeeze for Bioxytran occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIXT, which in turn drives the price of the stock up even further. How often is Bioxytran's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIXT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Benitec Biopharma Short Interest Data Cumberland Pharmaceuticals Short Interest Data CytoMed Therapeutics Short Interest Data MEI Pharma Short Interest Data Bullfrog AI Short Interest Data Orgenesis Short Interest Data Lumos Pharma Short Interest Data Alaunos Therapeutics Short Interest Data TherapeuticsMD Short Interest Data Synlogic Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BIXT) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetry